Tempus Executive and Leadership Team

Max Banaszak, the Chief Operating Officer, Data & Apps at Tempus, manages the operational execution of the company's data platforms and application development. Banaszak ensures the seamless functioning and continuous improvement of the systems that ingest, process, and analyze clinical and molecular data. This leadership role is pivotal in translating Tempus's mission of applying AI and machine learning to healthcare into tangible, operational realities. The Chief Operating Officer, Data & Apps oversees the teams responsible for maintaining the integrity and accessibility of the vast data libraries, which are crucial for precision medicine. Banaszak's focus includes optimizing workflows for data normalization and cleaning, ensuring the high quality of multimodal patient profiles generated by the proprietary system. By driving operational excellence in data and application management, Max Banaszak directly supports clinicians in utilizing Tempus's insights for targeted therapeutics and enhanced diagnostic capabilities across various medical specialties.

Monique Patrick, the Operations Executive & Chief Operating Officer, Supporting & Suite Executive at Tempus, oversees critical operational functions that support the company's broader strategic objectives. Patrick ensures the efficient execution of internal processes and the smooth functioning of support services essential for Tempus's advanced technology and data science initiatives. This leadership position involves managing key operational workflows that enable the seamless integration of clinical data and genomic insights. The Chief Operating Officer, Supporting & Suite Executive plays a vital role in optimizing resource allocation and driving operational improvements across various departments. Patrick's focus is on enhancing the overall efficiency and effectiveness of the organization, ensuring that Tempus can consistently deliver on its mission to transform healthcare through precision medicine. By strengthening operational infrastructure, Monique Patrick directly contributes to Tempus's capacity to provide clinicians with powerful tools for diagnosing and treating complex diseases.

Brett WagnerVice, the President, Western Region at Tempus, directs the company's strategic growth and market presence across the western United States. WagnerVice spearheads initiatives to expand Tempus's reach and impact within this key geographic area, focusing on building strong relationships with healthcare providers and institutions. This leadership role involves translating the company's mission of precision medicine into actionable strategies tailored for the western market. The President, Western Region oversees sales, business development, and operational alignment to ensure Tempus's advanced AI and genomic diagnostic solutions are effectively deployed. WagnerVice's responsibilities include driving revenue growth and market share by championing the benefits of data-driven therapeutic models for oncology, cardiology, and other critical diseases. Through strategic leadership, Brett WagnerVice ensures that clinicians in the western region have access to Tempus's transformative capabilities, advancing the adoption of personalized healthcare.

Matthew Oplinger, the Chief of Staff at Tempus, directs strategic initiatives and operational efficiency across the enterprise. Oplinger ensures seamless execution of corporate objectives by aligning departmental efforts with the company's core mission of integrating AI and machine learning into healthcare. This role involves close collaboration with executive leadership to refine business processes and drive cross-functional projects. Oplinger's oversight extends to managing key stakeholder communications and supporting the development of long-term strategic roadmaps. The Chief of Staff facilitates critical decision-making by synthesizing complex information and presenting actionable insights to senior management. By optimizing internal workflows, Matthew Oplinger directly contributes to Tempus's ability to deliver advanced genomic diagnostics and clinical data science solutions, thereby enhancing the precision medicine model for oncology, cardiology, and other critical disease areas.

Natasha Esprey, the Chief Information Officer at Tempus, architects and oversees the company's comprehensive information technology infrastructure. Esprey drives the strategic direction of all IT operations, ensuring robust security, scalability, and reliability for Tempus's advanced data platforms. This leadership position involves managing the integration of cutting-edge technologies that support the company's mission of applying AI and machine learning to healthcare data. Esprey's responsibilities include safeguarding vast libraries of clinical and molecular data, a critical component of Tempus's precision medicine approach. The Chief Information Officer ensures that IT systems effectively support the ingestion, normalization, and analysis of electronic health records and genomic sequencing data. By maintaining a secure and efficient technological backbone, Natasha Esprey enables clinicians to access and utilize multimodal patient profiles for targeted therapeutics and diagnostic insights, directly impacting the transformation of oncology and other disease treatments.

Patricia Spiller, the Chief Marketing Officer at Tempus, directs all aspects of the company's brand strategy and market engagement. Spiller crafts and executes comprehensive marketing initiatives designed to communicate the transformative power of Tempus's AI-driven precision medicine solutions to healthcare providers and partners. This role involves translating complex technological advancements in genomic diagnostics and clinical data science into compelling narratives that highlight improved patient outcomes. The Chief Marketing Officer oversees market research, product positioning, and demand generation efforts, ensuring Tempus's leadership in the healthcare technology sector is clearly articulated. Spiller's strategic vision guides the promotion of Tempus's unique data engine, which unifies clinical and molecular information to support tailored therapeutic models. By amplifying the company's impact, Patricia Spiller ensures that medical practitioners understand how Tempus empowers them to move beyond traditional treatments and embrace a data-driven approach to oncology, cardiology, and other critical medical fields.

Shane Colley, the Chief Technology Officer at Tempus, spearheads the development and implementation of the company's core technological innovations. Colley directs the engineering teams responsible for building and scaling the sophisticated AI and machine learning platforms that underpin Tempus's precision medicine initiatives. This critical role involves overseeing the architecture of the multi-faceted data engine, which integrates clinical records with advanced genomic sequencing data. The Chief Technology Officer ensures that Tempus's proprietary system efficiently ingests, normalizes, and analyzes vast datasets to generate comprehensive patient profiles. Colley's technical leadership is essential for deploying advanced neural networks and predictive modeling techniques that uncover genetic patterns and therapeutic correlations. By driving technological advancement, Shane Colley enables clinicians to select targeted therapeutics and forecast disease progression, thereby solidifying Tempus's position at the forefront of transforming healthcare through data science and algorithmic analysis.

Donavan Cheng, the Chief Technology Officer, Diagnostics at Tempus, leads the technological advancements within the company's diagnostic laboratory operations. Cheng directs the development and implementation of cutting-edge technologies for genomic sequencing and molecular diagnostics, ensuring the highest standards of accuracy and efficiency. This role is fundamental to Tempus's ability to generate the deep molecular data that fuels its AI-driven precision medicine platform. The Chief Technology Officer, Diagnostics oversees the integration of advanced laboratory automation and bioinformatics tools, optimizing the process of gathering critical patient information. Cheng's technical expertise ensures that the state-of-the-art laboratory facilities produce reliable and comprehensive data essential for creating multimodal patient profiles. By driving innovation in diagnostics technology, Donavan Cheng directly contributes to Tempus's mission of transforming healthcare and enabling clinicians to make more informed, data-driven treatment decisions for complex diseases.